Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcoma
Background: Previous studies have shown that aberrant activation of the Wnt/β-catenin pathway is associated with many malignant neoplasms. This includes some soft-tissue sarcoma phenotypes, most notably synovial sarcoma, implicating potential targets for novel molecular therapies. Objective: We inve...
Main Authors: | Laurence M Briski, Dafydd G Thomas, Rajiv M Patel, Elizabeth R Lawlor, Rashmi Chugh, Jonathan B McHugh, David R Lucas |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-11-01
|
Series: | Rare Tumors |
Online Access: | https://doi.org/10.1177/2036361318813431 |
Similar Items
-
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
by: Esther Martinez-Font, et al.
Published: (2021-11-01) -
LGR5 is expressed by Ewing sarcoma and potentiates Wnt/β-catenin signaling
by: Christopher A Scannell, et al.
Published: (2013-04-01) -
Synovial sarcoma: the misdiagnosed sarcoma
by: Chengxiang Li, et al.
Published: (2024-04-01) -
Synovial sarcoma
by: Sucari S.C. Vlok, et al.
Published: (2014-12-01) -
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
by: De Sanctis R, et al.
Published: (2015-10-01)